General Information of the Compound
Compound ID
CP0952904
Compound Name
(3S,6S,9S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S)-3-((2S,5S,8S,11S,14S,17S,20S,23S,24R)-11-((1H-indol-3-yl)methyl)-20-(2-amino-2-oxoethyl)-8-(3-amino-3-oxopropyl)-23-carbamoyl-24-hydroxy-14-isobutyl-5-isopropyl-17-(2-(methylthio)ethyl)-3,6,9,12,15,18,21-heptaoxo-1-phenyl-4,7,10,13,16,19,22-heptaazapentacosan-2-ylcarbamoyl)-6-(3-amino-3-oxopropyl)-30-(4-aminobutyl)-21-(carboxymethyl)-12,15-bis(3-guanidinopropyl)-39-((S)-3-hydroxy-2-((2S,3R)-3-hydroxy-2-((S)-2-hydroxy-3-phenylpropanamido)butanamido)propanamido)-27,36-bis(4-hydroxybenzyl)-18,33-bis(hydroxymethyl)-24-isobutyl-9-methyl-5,8,11,14,17,20,23,26,29,32,35,38-dodecaoxo-4,7,10,13,16,19,22,25,28,31,34,37-dodecaazadotetracontane-1,42-dioic acid
    Show/Hide
Formula
C134H197N35O41S
Molecular Weight
2986.321
Canonical SMILES
CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](O)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(N)=O)[C@@H](C)O
    Show/Hide
InChI
InChI=1S/C134H197N35O41S/c1-65(2)51-87(118(196)153-86(46-50-211-10)117(195)161-93(58-102(138)180)126(204)168-107(69(8)173)109(139)187)156-122(200)92(57-75-61-146-79-28-18-17-27-78(75)79)160-115(193)84(41-44-101(137)179)154-131(209)106(67(5)6)167-125(203)91(53-71-23-13-11-14-24-71)159-123(201)94(59-104(183)184)162-114(192)83(40-43-100(136)178)148-110(188)68(7)147-111(189)81(30-21-48-144-133(140)141)149-112(190)82(31-22-49-145-134(142)143)151-128(206)97(63-171)165-124(202)95(60-105(185)186)163-119(197)88(52-66(3)4)155-120(198)89(54-73-32-36-76(175)37-33-73)157-113(191)80(29-19-20-47-135)150-127(205)96(62-170)164-121(199)90(55-74-34-38-77(176)39-35-74)158-116(194)85(42-45-103(181)182)152-129(207)98(64-172)166-132(210)108(70(9)174)169-130(208)99(177)56-72-25-15-12-16-26-72/h11-18,23-28,32-39,61,65-70,80-99,106-108,146,170-177H,19-22,29-31,40-60,62-64,135H2,1-10H3,(H2,136,178)(H2,137,179)(H2,138,180)(H2,139,187)(H,147,189)(H,148,188)(H,149,190)(H,150,205)(H,151,206)(H,152,207)(H,153,196)(H,154,209)(H,155,198)(H,156,200)(H,157,191)(H,158,194)(H,159,201)(H,160,193)(H,161,195)(H,162,192)(H,163,197)(H,164,199)(H,165,202)(H,166,210)(H,167,203)(H,168,204)(H,169,208)(H,181,182)(H,183,184)(H,185,186)(H4,140,141,144)(H4,142,143,145)/t68-,69+,70+,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,106-,107-,108-/m0/s1
    Show/Hide
InChIKey
FYSYNCVDZVIZDU-XUFMKALWSA-N
Physicochemical Property
logP
-12.77516
Rotatable Bonds
97
Heavy Atom Count
211
Polar Areas
1281.01
Hydrogen Bond Donor Count
46
Hydrogen Bond Acceptor Count
42
Complexity
211

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4849980
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01473, Glucagon receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 40 nM
   TI
   LI
   LO
   TS